Work

Antiviral therapies are associated with reduced mortality but under-utilized in patients with viral hepatocellular carcinoma: a multinational REAL-HCC study

Year: 2026
Type: article
Study design: Observational Study
Abstract: Background and Aims: Antiviral treatment can reduce mortality of viral hepatocellular carcinoma (HCC) but may be underutilized. Methods: In a multinational real-world consortium of HCC patients with hepatitis B (HBV-HCC) or C (HCV-HCC) from 16 centers (7 countries/regions), we assessed treatment rates of nucleos(t)ide analogs in HBV-HCC (2007-2023) and direct acting antivirals in HCV-HCC (2015-2023). Results: Among 3,973 HCC patients (3,186 HBV, 647 HCV, 140 HBV/HCV), 49.7% of HBV-HCC and 63.2% of HCV-HCC patients received antiviral treatment. For HBV, lower treatment rates were observed in female (41.7% vs. 51.8%), older (>60) (45.3% vs. 54.5%), noncirrhosis (41.3% vs. 56.8%), and Asia region (37.9% vs. 85.0%) patients; for HCV, lower rates in male (59.0% vs. 72.4%), cirrhosis (60.5% vs. 73.2%), and non-Asia region (58.2% vs. 69.9%) patients, all P <0.005. Child A cirrhosis and Barcelona Clinic Liver Cancer (BCLC) 0/A patients had highest treatment rates followed by Child B and C or BCLC B, C, or D for both HBV (78.6%, 48.3%, 43.8%; 59.9%, 50.9%, 36.7%, 41.0%) and HCV (68.2%, 53.3%, 38.6%; 72.5%, 53.3%, 51.9%, 30.2%), all P <0.001. Factors independently associated with lower treatment rates were: female, age>60, Asia region, noncirrhosis, and BCLC B or C (vs. 0/A) for HBV; male, age>65, Child B or C cirrhosis (vs. non-cirrhosis), and BCLC B or C for HCV. Antiviral treatment was independently associated with reduced mortality in both HBV-HCC (adjusted hazard ratio [aHR]=0.82) and HCV-HCC (aHR=0.31) patients. Conclusion: Despite survival benefits, antiviral therapies were substantially underutilized in both HBV-HCC and HCV-HCC, particularly in advanced patients.
Language: English
Subfield: Epidemiology
Field: Medicine
Open Access status: green
OpenAlex ID: W7212219483
FWCI:
Cites: 31
Cited by:
Related to: 10